Patents by Inventor Gregory M. Whited

Gregory M. Whited has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7179932
    Abstract: The present invention is related to cis-diols and biological methods of producing cis-diols. The present invention further relates to processes for subsequently converting such silane cis-diols to the more stable acetonide derivatives, as well as a process for converting silane cis-diols to the corresponding catechols and the compounds produced thereby. The present invention also provides chemical methods for the conversion of said silane cis-diols and acetonide compounds to epoxy, saturated and otherwise modified derivatives. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that is will not be used to interpret or limit the scope or meaning of the claims 37 CFR 1.72(b).
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: February 20, 2007
    Assignee: Genencor International, Inc.
    Inventors: Joseph C. McAuliffe, Gregory M. Whited, Wyatt Charles Smith
  • Publication number: 20040033574
    Abstract: The present invention is related to cis-diols and biological methods of producing cis-diols. The present invention further relates to processes for subsequently converting such silane cis-diols to the more stable acetonide derivatives, as well as a process for converting silane cis-diols to the corresponding catechols and the compounds produced thereby. The present invention also provides chemical methods for the conversion of said silane cis-diols and acetonide compounds to epoxy, saturated and otherwise modified derivatives. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that is will not be used to interpret or limit the scope or meaning of the claims.
    Type: Application
    Filed: June 3, 2003
    Publication date: February 19, 2004
    Inventors: Joseph C. McAuliffe, Gregory M. Whited, Wyatt Charles Smith
  • Patent number: 6432686
    Abstract: Recombinant organisms are provided comprising genes encoding genes encoding glycerol dehydratase, 1,3-propanediol oxidoreductase, a gene encoding vitamin B12 receptor precursor(BtuB), a gene encoding vitamin B12 transport system permease protein(BtuC) and a gene encoding vitamin B12 transport ATP-binding protein (BtuD). The recombinant microorganism is contacted with a carbon substrate and 1,3-propanediol is isolated from the growth media.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: August 13, 2002
    Assignees: E. I. du Pont de Nemours and Company, Genencor International
    Inventors: Ben A. Bulthuis, Gregory M. Whited, Donald E. Trimbur, Anthony A. Gatenby
  • Patent number: 6013494
    Abstract: Recombinant organisms are provided comprising genes encoding glycerol-3-phosphate dehydrogenase, glycerol-3-phosphatase, glycerol dehydratase and 1,3-propanediol oxidoreductase activites useful for the production of 1,3-propanediol from a variety of carbon substrates.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: January 11, 2000
    Assignees: E. I. du Pont de Nemours and Company, Genencor International
    Inventors: Charles E. Nakamura, Anthony A. Gatenby, Amy Kuang-Hua Hsu, Richard D. La Reau, Sharon L. Haynie, Maria Diaz-Torres, Donald E. Trimbur, Gregory M. Whited, Vasantha Nagarajan, Mark S. Payne, Stephen K. Picataggio, Ramesh V. Nair
  • Patent number: 5476965
    Abstract: Provided are enzymatic methods for the selective hydrolytic resolution of certain enantiomers of a pharmaceutical compound, the pharmaceutical compound comprising a (.+-.) mixture of a .alpha.-substituted 2-methyl proprionic acid derivative. Specifically provided is the selective enzymatic resolution of either the R(+) or S(-) enantiomer of (.+-.)-ethyl ciprofibrate. Also provided are substantially pure enantiomers of R(+) and S(-) ciprofibrate.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: December 19, 1995
    Assignee: Genencor International, Inc.
    Inventors: Matthew W. Chase, Charles T. Goodhue, Robert Seemayer, Gregory M. Whited
  • Patent number: 5240835
    Abstract: Unsaturated esters can be converted into unsaturated polymerizable monomers using a biocatalyst derived from Corynebacterium oxydans. The method involves the step of reacting an unsaturated ester with an organic compound having a primary or secondary hydroxy group in a substantially organic environment in the presence of the noted biocatalyst. A transacylase has been isolated from the microorganism and at least partially purified.
    Type: Grant
    Filed: October 10, 1989
    Date of Patent: August 31, 1993
    Assignee: Genencor International, Inc.
    Inventors: Frank A. Pettrone, Patrick J. Grisdale, Gregory M. Whited, Theresa C. Paulson
  • Patent number: 5114850
    Abstract: Acetate esters of diols and polyols can be prepared in aqueous systems using a biocatalyst derived from Corynebacterium oxydans. The method involves the step of reacting a diol or polyol with an acetate ester in a substantially aqueous environment in the presence of said biocatalyst.
    Type: Grant
    Filed: June 22, 1990
    Date of Patent: May 19, 1992
    Assignee: Eastman Kodak Company
    Inventors: Frank A. Pettrone, Gregory M. Whited, Charles T. Goodhue